Skip to content

Dietary supplement and yogic practices for joints pain.

Effect of Amalakyadi Rasayana Chutney and Yogic Practices in the Management of Sandhivata(Osteoarthritis)- A Comparative Randomized Controlled Open Label Clinical Trial.

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/025867
Enrollment
20
Registered
2020-06-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M199- Osteoarthritis, unspecified site

Interventions

Intervention1: Amlakyadi Rasayan Chutney 5gm BD for two months: Efeect of Amlakyadi Rasayan Chutney on Osteoarthritis Control Intervention1: Trayodashang Gugglu 500MG BD For Two Months: Medicine

Sponsors

All India Institue Of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients suffering from primary osteoarthritis. 2.Patients with classical sign and symptoms of Sandhivata(Osteoarthritis)like Shool(Joint pain),Shotha(Joint edema),Stambha(Stiffenes),Sparshaasahyata (Tenderness),Atopa(Crepitus)Akunchana-Prasaranavedana(Pain during flexion and extension of the joint)etc.at the affected joints.

Exclusion criteria

Exclusion criteria: 1.Those who are not willing to participate in the study. 2.Patient unable or not willing to perform yoga. 3.Stage 4 OA as the joint space between bones is dramatically reduced-the cartilage is almost completely gone,leaving the joint stiff and possibly immobile. 4.Patient suffering from cardio-vascular diseases,Vatarakta,Amavata,Pregnancy and lactation,or any other systemic illness.

Design outcomes

Primary

MeasureTime frame
Alleviation of symptoms of Sandhivata in trial group as compared to control group.Timepoint: 2 Months

Secondary

MeasureTime frame
Improvement in quality of life in trial group as compared to control group.Timepoint: 2 Months

Countries

India

Contacts

Public ContactMedha Kulkarni

All India Institute Of Ayurveda

Medha63@rediffmail.com9890355305

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026